OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273
Ivan T. Lee, Catherine A. Cosgrove, Patrick Moore, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Ivan T. Lee, Catherine A. Cosgrove, Patrick Moore, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Showing 9 citing articles:
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial
Chijioke Bennett, Wayne Woo, Mark Bloch, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 6, pp. 581-593
Open Access | Times Cited: 7
Chijioke Bennett, Wayne Woo, Mark Bloch, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 6, pp. 581-593
Open Access | Times Cited: 7
A Meta-Analysis on the Immunogenicity of Prototype, Monovalent-adapted and Bivalent vaccines against SARS-CoV-2 Wildtype, Omicron BA.1 and Omicron BA.4/5 in Healthy Adults.
Jo‐Lewis Banga Ndzouboukou, Abdul A. Kamara, Nadeem Ullah, et al.
Virology (2025) Vol. 606, pp. 110509-110509
Closed Access
Jo‐Lewis Banga Ndzouboukou, Abdul A. Kamara, Nadeem Ullah, et al.
Virology (2025) Vol. 606, pp. 110509-110509
Closed Access
The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report
Ssu-Yu Chen, Chien‐Yu Lin, Hsin Chi, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2094-2094
Open Access | Times Cited: 7
Ssu-Yu Chen, Chien‐Yu Lin, Hsin Chi, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2094-2094
Open Access | Times Cited: 7
Bivalent Covid-19 Vaccines
Peter Marks, Robert M. Califf
New England Journal of Medicine (2023) Vol. 388, Iss. 12, pp. 1151-1152
Open Access | Times Cited: 5
Peter Marks, Robert M. Califf
New England Journal of Medicine (2023) Vol. 388, Iss. 12, pp. 1151-1152
Open Access | Times Cited: 5
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial
Angela R. Branche, Nadine Rouphael, David Diemert, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
Angela R. Branche, Nadine Rouphael, David Diemert, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial
Chijioke Bennett, Elizabeth Rivers, Wayne Woo, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. e4-e16
Open Access | Times Cited: 3
Chijioke Bennett, Elizabeth Rivers, Wayne Woo, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. e4-e16
Open Access | Times Cited: 3
Interim Safety and Immunogenicity of COVID-19 Omicron-BA.1 Variant-Containing Vaccine in Children
Avika Dixit, Richard L. Bennett, Kashif Ali, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Avika Dixit, Richard L. Bennett, Kashif Ali, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial
Chijioke Bennett, Elizabeth Rivers, Wayne Woo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Chijioke Bennett, Elizabeth Rivers, Wayne Woo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment”
Rituparna Das, Randall N. Hyer, Paul R. Burton, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access
Rituparna Das, Randall N. Hyer, Paul R. Burton, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access
Humoral and cellular response three months following bivalent booster administration
Julien Favresse, Constant Gillot, Jean‐Louis Bayart, et al.
Research Square (Research Square) (2023)
Open Access
Julien Favresse, Constant Gillot, Jean‐Louis Bayart, et al.
Research Square (Research Square) (2023)
Open Access
